Important Disclosure: TheStreetSweeper has sold 80,599 shares of QCOR short at an average price of $41.46 a share in anticipation of a future decline in the stock price." Questcor has been unable to determine the exact nature of …
In the most recently reported period, EPS erupted 96% and revenue 64%. Sales for all of last year were $621 million. Questcor's stock reflects the Bailey bulge, marching 4,000% since late 2007. Bailey was born in Pittsburgh in 1946. At …
Boston, MA 04/07/2014 (wallstreetpr) – Ireland’s Mallinckrodt has announced it his inline to complete the acquisition of …
Aug. 13, 2008 (PRIME NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it has …
For traders using PowerRatings to find the best stocks to trade every day, this may have been enough to put QCOR on the “stocks to watch” list. When the stock earned a further PowerRatings upgrade to 9, even the most conservative …
The 16% price increase comes on the news that Questcor is being acquired by an Irish specialty-pharmaceutical company, Mallinckrodt, in a deal worth $5.6 billion in cash and stock. It is worth noting, as always in these cases, that …
As a result of the merger, shareholders are anticipated to receive $30 in cash and .897 shares of Mallinckrodt for each …
Of this amount, $0.6 million, during the second quarter, and $1.8 million, during the six month period, were related to the Company's Employee Stock Purchase Plan (ESPP). In February 2008, Questcor's Board of Directors approved a …
Questcor's stock leapt nearly 40% during trading yesterday as investors welcomed its $135m-plus purchase of Novartis' rival immune drug Synacthen. The US speciality pharma said it has bought rights to develop Synacthen (tetracosactide) …
After the deal closes, Mallinckrodt shareholders will own about 50.5 percent and former Questcor shareholders will own about 49.5 percent of the combined company's stock. Both companies' boards unanimously approved the transaction. …